StockData
Niagen Bioscience, Inc. logo

Niagen Bioscience, Inc. (NAGE) stock

NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3016% below fair value
$1.84−0.03 (-1.60%)

Close on Nov 20, 2026Market cap $145.59MP/E 15.3Yield –

Niagen Bioscience free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Niagen Bioscience's free cash flow for the twelve months ending Sep 30, 2020 was -$11.66M. For fiscal 2019 it was -$21.18M. The highest annual figure on record is -$2.64M in fiscal 2015.

Annual free cash flow

PeriodPeriod endValueChange
FY2019Dec 31, 2019-$21.18M–
FY2018Dec 31, 2018-$22.23M–
FY2017Dec 30, 2017-$10.97M–
FY2016Dec 31, 2016-$4.44M–
FY2015Jan 2, 2016-$2.64M–
FY2014Jan 3, 2015-$2.70M–
FY2013Dec 28, 2013-$4.04M–
FY2012Dec 29, 2012-$10.14M–
FY2011Dec 31, 2011-$4.25M–
FY2010Jan 1, 2011-$2.83M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2020Sep 30, 2020-$3.89M–
Q2 FY2020Jun 30, 2020-$1.65M–
Q1 FY2020Mar 31, 2020-$5.24M–
Q4 FY2019Dec 31, 2019-$890.00K–
Q3 FY2019Sep 30, 2019-$7.92M–
Q2 FY2019Jun 30, 2019-$9.09M–
Q1 FY2019Mar 31, 2019-$3.29M–
Q4 FY2018Dec 31, 2018-$5.15M–
Q3 FY2018Sep 30, 2018-$5.27M–
Q2 FY2018Jun 30, 2018-$7.66M–
Q1 FY2018Mar 31, 2018-$4.15M–
Q4 FY2017Dec 30, 2017-$4.06M–
Q3 FY2017Sep 30, 2017-$1.05M–
Q4 FY2016Dec 31, 2016-$372.76K–
Q3 FY2016Oct 1, 2016-$850.17K–

More Niagen Bioscience figures

See a number that looks wrong?